Thermo Fisher Scientific Inc. (TMO)
Thermo Fisher Scientific Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Thermo Fisher Scientific Inc. (TMO) is a Medical - Diagnostics & Research company based in US with a market capitalization of $185.1B. Revenue grew 3.9% year-over-year and the company generated $6.3B in free cash flow. This page tracks TMO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 125K employees · IPO Mar 17, 1980
Valuation
Valuation & price
$446.10as of May 13, 2026· -30.2% vs 52w high
25.0
P/E ratio
Latest-FY diluted EPS
3.47
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$185.1B
Market cap
3.9%
Revenue growth (YoY)
37.7%
Gross margin
$6.3B
Free cash flow (USD)
$30.7B
Net debt
-1.6%
Share dilution
2/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
1
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 1, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Thermo Fisher Scientific Inc.'s market cap?
Thermo Fisher Scientific Inc. (TMO) has a market capitalization of $185.1B.
What is TMO's P/E ratio?
TMO trades at a price-to-earnings ratio of 25.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is TMO's price-to-book (P/B) ratio?
TMO trades at 3.47 times book value per share.
Are insiders buying TMO stock?
SEC Form 4 filings show no open-market insider buys at Thermo Fisher Scientific Inc. in the last 90 days (1 sell).
Same arena
Related companies in Medical - Diagnostics & Research
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.